The combination of
photothermal therapy and
chemotherapy are developing as a promising clinical strategy but it urgently needs the high exploration of intelligent multifunctional
drug delivery nanovectors. In this paper, we used a versatile method to construct mesoporous
polydopamine nanovehicles (
MPDA) with the dendritic mesopores loaded with a clinical chemotherapeutic
drug,
Doxorubicin (
MPDA@DOX). The monodisperse nanoagents are spherical with a size of ∼160 nm and pore size of approximately 10 nm.
MPDA could efficiently delivery DOX with π-π stacking interaction and acts as the potent photothermal agents. Importantly,
MPDA@DOX are preferentially internalized by cancerous cells, then bursting drug release and
local hyperthermia generation were observed in conditions representative of the cytoplasm in
tumor cells that highly synergistic cell killing effect were found under 808 nm
laser irradiation. The fluorescent imaging results of human
breast tumor bearing murine model evidenced that
MPDA delivery platform have excellent
tumor precise targeting effect and in vivo
tumor ablation experiment further revealed that
MPDA@DOX showed markedly eradicated
tumor growth capability under
laser exposure. Therefore, this work provided a fascinating strategy based on biocompatible
MPDA based drug delivery system for malignant
tumors eradication via synergistic
therapy.